AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 ParticipantsBenzinga • 09/01/20
GAAPP and AstraZeneca launch campaign to help asthma patients break over-reliance on their SABA 'blue' reliever inhaler to prevent asthma attacksPRNewsWire • 09/01/20
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20
COVID-19 Treatments: Remdesivir Disappoints, Antiviral SPL7013 And Monoclonal Antibodies Interesting For Prevention/Early-Stage TreatmentSeeking Alpha • 08/27/20
AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FTBenzinga • 08/26/20
AstraZeneca Starts Clinical Trial Testing Its COVID-19 Treatment Antibody CocktailThe Motley Fool • 08/25/20
AstraZeneca stock price gains as Trump considers fast-tracking their COVID-19 vaccineInvezz • 08/25/20
AstraZeneca Coronavirus Treatment Testing Begins; 'Important Milestone'Investors Business Daily • 08/25/20
Billions Pouring Into Drugs That Could Treat Cancer Patients with High TROP2 ExpressionsPRNewsWire • 08/25/20
AstraZeneca Might Receive Emergency Use Authorization for Its Coronavirus VaccineThe Motley Fool • 08/24/20